E-CADHERIN IMMUNOSTAINING OF BLADDER TRANSITIONAL CELL CARCINOMA, CARCINOMA IN SITU AND LYMPH NODE METASTASES WITH LONG-TERM FOLLOWUP
Authors:
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (5) , 1473-1479
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mechanisms associated with abnormal E-cadherin immunoreactivity in human bladder tumorsInternational Journal of Cancer, 1999
- ALTERED gamma-CATENIN EXPRESSION CORRELATES WITH POOR SURVIVAL IN PATIENTS WITH BLADDER CANCERJournal of Urology, 1998
- Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell CarcinomaJournal of Urology, 1995
- Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancerJournal of Cancer Research and Clinical Oncology, 1995
- Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stageThe Journal of Pathology, 1994
- Decreased E-Cadherin Expression in Endometrial Carcinoma Is Associated with Tumor Dedifferentiation and Deep Myometrial InvasionGynecologic Oncology, 1994
- A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis.Journal of Cell Biology, 1991
- E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.Journal of Cell Biology, 1991
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991
- Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarityCell, 1990